ClinicalTrials.gg
CompletedNCT06466837Updated Sep 17, 2026

Just-In-Time Adaptive Interventions for Diabetic Patients

An interventional study of Just-in-time intervention and Active control in Diabetes, Self-Control and Telemedicine, sponsored by The Hong Kong Polytechnic University. Completed at 1 site in Hong Kong. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by The Hong Kong Polytechnic University · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
184
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The addition of proactive nurse consultations was useful to older adults with diabetes mellitus in facilitating their chronic disease self-management. However, the service is time and resource-intensive. With the support of advanced technology, mhealth App seems to be a convenient way to support patients in managing diabetes.

Read the detailed description

This study examines the effectiveness of mhealth App plus nurse consultations in promoting self-management behaviours for diabetic patients.

02

Conditions studied

  • Diabetes
  • Self-Control
  • Telemedicine

Keywords

  • telecare
  • older adults
  • diabetes
03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's enrollment of 184 is above the median of 80 across 6,023 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

The Hong Kong Polytechnic University is the lead sponsor of 679 studies on the registry; 257 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • With a confirmed DM diagnosis for one year or more than one year
  • Using governmental mhealth App
  • Living in an area with Internet coverage

Exclusion criteria

Exclusion Criteria:

  • Already engaged in other mHealth programmes
  • Physical and cognitive limitations
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
184 participants (actual)

Study arms

  • Experimental
    Just-in-time Intervention

    They will receive just-in-time intervention and 3 monthly nursing consultations.

    Behavioral: Just-in-time intervention

  • Active comparator
    Active Control

    They will receive 6 bi-weekly nursing consultations.

    Behavioral: Active control

Interventions

  • BehavioralJust-in-time intervention

    The intervention group participants will receive just-in-time intervention from a developed app for healthy behavior reminder

  • BehavioralActive control

    The control group participants will receive six nursing consultations during the 3-month program period.

06

What researchers measure

Primary outcomes

  1. Change in HbA1c

    Measured using the A1C Now device, with blood drawn from the subjects' finger

    Time frame: baseline, three-month, and six-month

  2. Diabetic self-management behaviour

    measured using the Summary of Diabetes Self-care. Total scores range from 0 to 42, with higher scores representing better self-management performance. Activities questionnaire

    Time frame: baseline, three-month, and six-month

Secondary outcomes

  1. Change in quality of life

    By using the Chinese version of the 12-item Short Form Health Survey. Total score ranges from 0 to 100, higher the better. version 2

    Time frame: baseline, three-month, and six-month

  2. Change in medication adherence

    Measure this by using the Adherence to Refills and Medications Scale. Scores from 12 to 48, higher score better medication adherence.

    Time frame: baseline, three-month, and six-month

  3. Change in health service utilization

    Measure the total number of unscheduled visits to general out-patient departments, general practitioners, emergency departments, and hospitals, and the total frequency of health service attendance

    Time frame: baseline, three-month, and six-month

  4. Cost

    The cost of the app, including development of new features and maintenance costs, will be estimated from the provider and societal perspectives, including the subjects' travelling costs and time. An ingredient approach will be adopted to estimate the cost.

    Time frame: three-month, and six-month

  5. satisfaction with the JITAIs, as well as usability and technical problems

    using semi-structured group interviews with the intervention group participants

    Time frame: three-month

07

Study locations

1 site
  • District Health Center
    Hong Kong, Hong Kong
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2024 to primary completion in May 2026, 20 months.

Of 1,583 non-industry interventional studies with no phase under Diabetes Mellitus, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's 20 months is below that.

Counting every sponsor, half of 1,743 studies reached it within 21 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2024
First posted
Jun 20, 2024
StartActual
Sep 1, 2024
Primary completionActual
May 1, 2026
CompletionActual
Aug 31, 2026
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06466837
Responsible party
Arkers, Wong (Associate Professor, The Hong Kong Polytechnic University) — Principal investigator
First posted
Jun 20, 2024
Start date
Sep 1, 2024
Primary completion
May 1, 2026
Completion
Aug 31, 2026
Last update
Sep 17, 2026

Study contacts

Arkers Wong, PhD
principal investigator · The Hong Kong Polytechnic University
Arkers NR Wong
principal investigator · The Hong Kong Polytechnic University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion